nach oben

Annals of Nuclear Medicine

Erschienen in:

01.12.2011 | Original article

Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson’s disease patients

verfasst von: I-Cheng Chang, Kun-Han Lue, Hung-Jen Hsieh, Shu-Hsin Liu, Chih-Hao K. Kao

Erschienen in: Annals of Nuclear Medicine | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

6-[¹⁸F]Fluoro-l-DOPA (FDOPA) is a radiopharmaceutical valuable for assessing the presynaptic dopaminergic function when used with positron emission tomography (PET). More specifically, the striatal-to-occipital ratio (SOR) of FDOPA uptake images has been extensively used as a quantitative parameter in these PET studies. Our aim was to develop an easy, automated method capable of performing objective analysis of SOR in FDOPA PET images of Parkinson’s disease (PD) patients.

Methods

Brain images from FDOPA PET studies of 21 patients with PD and 6 healthy subjects were included in our automated striatal analyses. Images of each individual were spatially normalized into an FDOPA template. Subsequently, the image slice with the highest level of basal ganglia activity was chosen among the series of normalized images. Also, the immediate preceding and following slices of the chosen image were then selected. Finally, the summation of these three images was used to quantify and calculate the SOR values. The results obtained by automated analysis were compared with manual analysis by a trained and experienced image processing technologist.

Results

The SOR values obtained from the automated analysis had a good agreement and high correlation with manual analysis. The differences in caudate, putamen, and striatum were −0.023, −0.029, and −0.025, respectively; correlation coefficients 0.961, 0.957, and 0.972, respectively.

Conclusions

We have successfully developed a method for automated striatal uptake analysis of FDOPA PET images. There was no significant difference between the SOR values obtained from this method and using manual analysis. Yet it is an unbiased time-saving and cost-effective program and easy to implement on a personal computer.

Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease: pathophysiologic and clinical implications. N Engl J Med. 1988;318:876–80.PubMedCrossRef

Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature. 1983;305:137–8.PubMedCrossRef

Nahmias C, Garnett ES, Firnau G, Lang A. Striatal dopamine distribution in parkinsonian patients during life. J Neurol Sci. 1985;69:223–30.PubMedCrossRef

Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, et al. Brain dopamine metabolism in patients with Parkinson’s disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry. 1986;49:853–60.PubMedCrossRef

Morrish PK, Sawle GV, Brooks DJ. An [¹⁸F]dopa-PET and clinical study of the rate of progression in Parkinson’s disease. Brain. 1996;119:585–91.PubMedCrossRef

Takikawa S, Dhawan V, Chaly T, Robeson W, Dahl R, Zanzi I, et al. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. J Nucl Med. 1994;35:955–63.PubMed

Ishikawa T, Dhawan V, Chaly T, Margouleff C, Robeson W, Dahl JR, et al. Clinical significance of striatal DOPA decarboxylase activity in Parkinson’s disease. J Nucl Med. 1996;37:216–22.PubMed

Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-βCIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med. 1996;37:1760–5.PubMed

Dhawan V, Ma Y, Pillai V, Spetsieris P, Chaly T, Belakhlef A, et al. Comparative analysis of striatal FDOPA uptake in Parkinson’s disease: ratio method versus graphical approach. J Nucl Med. 2002;43:1324–30.PubMed

10.

Eshuis SA, Maguire RP, Leenders KL, Jonkman S, Jager PL. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease. Eur J Nucl Med Mol Imaging. 2006;33:200–9.PubMedCrossRef

11.

Eshuis SA, Jager PL, Maguire RP, Jonkman S, Dierckx RA, Leenders KL. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls. Eur J Nucl Med Mol Imaging. 2009;36:454–62.PubMedCrossRef

12.

Jokinen P, Helenius H, Rauhala E, Brück A, Eskola O, Rinne JO. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med. 2009;50:893–9.PubMedCrossRef

13.

Huang WS, Chiang YH, Lin JC, Chou YH, Cheng CY, Liu RS. Crossover study of ^99mTc-TRODAT-1 SPECT and ¹⁸F-FDOPA PET in Parkinson’s disease. J Nucl Med. 2003;44:999–1005.PubMed

14.

Friston KJ, Ashburner J, Frith CD, Poline J-B, Heather JD, Frackowiak RSJ. Spatial registration and normalization of images. Hum Brain Mapp. 1995;2:165–89.CrossRef

15.

Ashburner J, Neelin P, Collins DL, Evans A, Friston KJ. Incorporating prior knowledge into image registration. Neuroimage. 1997;6:344–52.PubMedCrossRef

16.

Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7:254–66.PubMedCrossRef

17.

Kao CH, Hsu WL, Xie HL, Lin MC, Lan WC, Chao HY. GMP production of [¹⁸F]FDOPA and issues concerning its quality analyses as in USP “Fluorodopa F 18 injection”. Ann Nucl Med. 2011;25:309–16.PubMedCrossRef

18.

Meyer JH, Gunn RN, Myers R, Grasby PM. Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage. 1999;9:545–53.PubMedCrossRef

19.

Gispert JD, Pascau J, Reig S, Martínez-Lázaro R, Molina V, García-Barreno P, et al. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. Neuroimage. 2003;19:601–12.PubMedCrossRef

20.

Collignon A, Maes F, Delaere D, Vandermeulen D, Suetens P, Marchal G. Automated multi-modality image registration based on information theory. In: Bizais Y, Barillot C, Di Paolo R, editors. Information processing in medical imaging. Dordrecht: Kluwer Academic Publishers; 1995. p. 263–74.

21.

Studholme C, Hill DLG, Hawkes DJ. An overlap invariant entropy measure of 3D medical image alignment. Pattern Recognit. 1999;32:71–86.CrossRef

22.

Evans AC, Collins DL, Mills SR, Brown ED, Kelly RL, Peters TM. 3D statistical neuroanatomical models from 305 MRI volumes. In: Proceedings of the IEEE Nuclear Science Symposium and Medical Imaging Conference; 1993. p. 1813–7.

23.

Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.PubMedCrossRef

24.

Habraken JB, Booij J, Slomka P, Sokole EB, van Royen EA. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm. J Nucl Med. 1999;40:1091–7.PubMed

25.

Radau PE, Linke R, Slomka PJ, Tatsch K. Optimization of automated quantification of ¹²³I-IBZM uptake in the striatum applied to parkinsonism. J Nucl Med. 2000;41:220–7.PubMed

26.

Buchert R, Berding G, Wilke F, Martin B, von Borczyskowski D, Mester J, et al. IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies. Eur J Nucl Med Mol Imaging. 2006;33:1073–83.PubMedCrossRef

27.

Zubal IG, Early M, Yuan O, Jennings D, Marek K, Seibyl JP. Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson’s disease patients. J Nucl Med. 2007;48:857–64.PubMedCrossRef

28.

Mirzaei S, Zakavi R, Rodrigues M, Schwarzgruber T, Brücke T, Bakala J, et al. Fully automated 3D basal ganglia activity measurement in dopamine transporter scintigraphy (Spectalyzer). Ann Nucl Med. 2010;24:295–300.PubMedCrossRef

29.

Seibyl JP. Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders. Semin Nucl Med. 2008;38:274–86.PubMedCrossRef

30.

Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195:310–20.PubMedCrossRef

Titel: Automated striatal uptake analysis of 18F-FDOPA PET images applied to Parkinson’s disease patients
verfasst von: I-Cheng Chang
Kun-Han Lue
Hung-Jen Hsieh
Shu-Hsin Liu
Chih-Hao K. Kao
Publikationsdatum: 01.12.2011
Verlag: Springer Japan
Erschienen in: Annals of Nuclear Medicine / Ausgabe 10/2011
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-011-0533-8

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson’s disease patients

Abstract

Objective

Methods

Results

Conclusions

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2011

Evaluation of organ-specific glucose metabolism by 18F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance

Utilization of nuclear medicine scintigraphy in Taiwan, 1997–2009

Additional effects of FDG-PET to thin-section CT for the differential diagnosis of lung nodules: a Japanese multicenter clinical study

Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: a Japanese multicenter clinical study

Myocardial washout rate of technetium-99m-sestamibi in the chronic phase predicts myocardial damage in patients with previous myocardial infarction

Impact of FDG-PET/CT in the management of lymphoma